Adjuvant Chemoradiotherapy Survival Data for 87 Advanced Gastric Cancer Patients

87 patients with advanced gastric adenocarcinoma (stages IB to IIIC) were retrospectively analyzed after undergoing subtotal or total gastrectomy with D2 lymphadenectomy. The study by Nelson Adami Andreollo assessed survival outcomes for patients who received adjuvant chemoradiotherapy under the INT 0116 protocol. 45 patients (51.7%) completed the full adjuvant treatment, while 33 (48.3%) did not start or refused it.

Use Cases

• Predicting patient survival based on tumor staging and lymph node invasion mentioned in the description
• Comparing treatment efficacy between complete and incomplete adjuvant chemoradiotherapy regimens
• Analyzing the impact of gastrectomy type (subtotal vs. total) on patient outcomes
• Identifying predictors of worse survival, such as advanced tumor stage (T4b)

Strengths

• Includes data on 87 patients with detailed treatment and outcome tracking
• Reports specific completion rates for adjuvant therapy (51.7% completed)
• Analyzes multiple clinical factors: tumor site, histopathology, lymph node invasion, staging, morbidity, and survival

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Last update date is unknown; freshness unverified

Provenance

Source

Nelson Adami Andreollo via paperswithcode

Collection Method

Retrospective analysis of patient records